About Indaco Venture Partners
Indaco Venture Partners is a venture capital firm founded in 2016. It is primarily based out of Milan, Italy. As of Oct 2026, Indaco Venture Partners is an active investor, having invested in 65 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in Italy based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series D round of Nouscom Overall, Indaco Venture Partners portfolio has seen 5 IPOs and 9 acquisitions including key companies like Newcleo, The Data Appeal Company and UltraSoC. A lot of funds co-invest with Indaco Venture Partners, with names like CDP Venture Capital sharing a substantial percentage of its portfolio. Indaco Venture Partners has team of 19 people including 12 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 4 more
Portfolio Acquisitions
Portfolio Soonicorns
Indaco Venture Partners' List of Top Investments
Indaco Venture Partners has a portfolio of 65 companies. Their most notable investments are in IAMA Therapeutics and EasyRain.Their portfolio spans across Italy, United States, United Kingdom and 8 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 23 other sectors, across stages such as Series A, Seed and 4 more. Here is the list of top investments by Indaco Venture Partners:
1. GP Bullhound
Provider of advisory and capital solutions for technology sector companies. It provides advice to private equity firms throughout their entire ownership lifespan in the industry and helps them raise the appropriate kind of financing. The firm delivers insights through reports, blogs, and other media. It focuses on supporting businesses in the technology landscape.
Key facts about GP Bullhound
- Founded Year: 1999
- Location: London (United Kingdom)
- Annual Revenue: £1M - £10M as on Dec 31, 2025
- Valuation: $*****
- Stage: Early Stage
- Total Funding till date: $3.9M
- Employee Count: 151 as on Sep 30, 2026
- Investors: Backstage, Mojo.capital and 7 Others
- Latest Funding Round: Unattributed, Jan 30, 2022, $*****
2. D-Orbit
Operator of orbital transportation, in-orbit servicing, and mission control software. The company provides last-mile satellite delivery and space waste management services. It offers solutions for hosted payload operations and space cloud computing. The company also develops systems and components for traditional and new space markets.
Key facts about D-Orbit
- Founded Year: 2011
- Location: Fino Mornasco (Italy)
- Stage: Series D
- Total Funding till date: $223M
- Employee Count: 432 as on Sep 30, 2026
- Investors: Indaco Venture Partners, United Ventures and 35 Others
- Latest Funding Round: Series D, Jan 22, 2026, $*****
- Highlight: Editors' Pick
3. Newcleo
Provider of advanced nuclear energy technologies, focused on designing, building, and operating small modular lead-cooled fast reactors. The company focuses on small modular reactors that recycle nuclear waste into fuel, closing the fuel cycle for sustainable power. The reactors use liquid lead cooling and fast neutron flux to avoid long-lived radioactive waste like plutonium and reduce the need for geological storage.
Key facts about Newcleo
- Founded Year: 2021
- Location: Paris (France)
- Annual Revenue: £1M - £10M as on Dec 31, 2023
- Stage: Public
- Total Funding till date: $843M
- Employee Count: 608 as on Sep 30, 2026
- Investors: Exor, Indaco Venture Partners and 74 Others
- Latest Funding Round: Series B, Feb 04, 2026, $*****
- Highlight: Public
_1580125123202.png?format=webp&height=120&width=120){kind=logo}
4. Pi-Cardia
Pi-cardia manufactures non-implant devices for valve repair. The product Leaflex provides lines that create separation between the calcium deposits on the two sides of the scoring line, in order to regain leaflets flexibility, allow their mobility and improve valve hemodynamics.
Key facts about Pi-Cardia
- Founded Year: 2009
- Location: Rehovot (Israel)
- Stage: Series D
- Total Funding till date: $40M
- Employee Count: 100 as on Sep 30, 2026
- Investors: Kreos Capital, Accelmed and 9 Others
- Latest Funding Round: Series D, Sep 01, 2026, $*****
- Highlight: Editors' Pick
5. WISE
WISE is a provider of solutions for neuromodulation and neuromonitoring. It has developed minimally invasive, biocompatible, foldable, and stretchable implantable leads for neuromodulation and neuromonitoring. The foldable nature of their electrodes and wires enables them to be implanted into the area of interest such as spine through a minimally invasive surgery. It provides a flexible electrode that can be folded and introduced into the spinal column using a catheter, thereby allowing it to be used to treat back pain and others. It also provides solutions for mapping of brain activity and pre-surgical epilepsy monitoring. Wise produces their electrodes through a proprietary process called supersonic cluster beam implantation (SCBI) technology, whereby nanoparticles of platinum and iridium are embedded into a silicon-based substrate, creating a composite layer below the surface that becomes an electro-conductive skin.
Key facts about WISE
- Founded Year: 2011
- Location: Milan (Italy)
- Stage: Series D
- Total Funding till date: $91.4M
- Employee Count: 59 as on Sep 30, 2026
- Investors: Indaco Venture Partners, European Investment Bank and 12 Others
- Latest Funding Round: Series D, Jun 17, 2026, $*****
- Highlight: Editors' Pick
Indaco Venture Partners' Year-on-Year Investment Trends
Indaco Venture Partners has invested in 65 companies over the last 18 years, with an average of 3 new investments annually in the last 10 years. In 2025, it made 6 investments, while as of Oct 2026, it has made 2 investments in this year. Its most recent first time investment was in Newcleo and most recent follow-on round was in Nouscom.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 3 | 3 | 6 |
2024 | 3 | 3 | 6 |
2023 | 4 | 2 | 6 |
2022 | 3 | 1 | 4 |
2021 | 2 | 2 | 4 |
2020 | 4 | 0 | 4 |
2019 | 9 | 0 | 9 |
2018 | 3 | 0 | 3 |
Indaco Venture Partners' Investments by Stage
Indaco Venture Partners has made 14 investments in Series A stage with an average round size of $14.5M, 11 investments in Seed stage with an average round size of $3.21M and 6 investments in Series B stage with an average round size of $34.6M.Stage of entry | No. of Investments |
|---|---|
Series A | 14 |
Seed | 11 |
Series B | 6 |
Series C | 3 |
Unattributed | 2 |
Others | 1 |
Note: We have considered here, only first round of investments
Indaco Venture Partners' Investments by Sector
Indaco Venture Partners has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, High Tech, Semiconductors and Consumer. Notably, it has invested in 51 Enterprise (B2B) companies, 49 Tech companies, 19 Software companies and at least 15 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 17 |
Enterprise Applications | 7 |
High Tech | 7 |
Semiconductors | 4 |
Consumer | 3 |
Others | 18 |
Note: We have considered here, only first round of investments
Indaco Venture Partners' Investments by Geography
Indaco Venture Partners has made most investments in Italy (27), followed by United States where it has made 3 investments.Country | No. of Investments |
|---|---|
Italy | 27 |
United States | 3 |
Denmark | 2 |
Switzerland | 2 |
Czech Republic | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
Indaco Venture Partners' recent investments
Indaco Venture Partners has made 2 investments in 2026 so far - Nouscom and Newcleo.Here are the most recent investments by Indaco Venture Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 19, 2026 | Switzerland | Series D | 6701 | [+12] | |
Feb 04, 2026 | France | Series B | 5485 | [+7] | |
Sep 12, 2025 | Italy | Series A | 2435 | ||
Apr 17, 2025 | Italy | Series B | 8000 | ||
Mar 24, 2025 | Italy | Series A | 3502 | [+5] |
IPOs and Publicly Listed companies in Indaco Venture Partners' Portfolio
5 of Indaco Venture Partners' portfolio companies have become public. Newcleo got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Sep 2026 and Almawave got listed on the Euronext Exchange (Euronext).Here are Indaco Venture Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 22, 2026 | Feb 04, 2026 | Series B | 4679 | |
Mar 12, 2021 | - | - | 1713 | |
May 27, 2016 | - | - | 8722 | |
Feb 21, 2014 | Jul 2011 | Seed | 3789 | |
Jan 09, 2014 | May 05, 2020 | Post IPO | 4970 |
Acquired companies in Indaco Venture Partners' Portfolio
9 companies from Indaco Venture Partners' portfolio have been acquired. The most recent acquisition was Cortilia in Sep 2026 by Renzo Rosso for $*****.Here are Indaco Venture Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 10, 2026 | Sep 17, 2019 | Series B | 9316 | |
Dec 31, 2021 | Oct 02, 2018 | Series A | 1412 | |
Aug 12, 2020 | - | - | 2747 | |
Jun 23, 2020 | Jun 24, 2019 | Series A | 2736 | |
Nov 20, 2019 | - | - | 7731 |
Team profile of Indaco Venture Partners
Indaco Venture Partners has a team of 19 members including 12 Partners and 2 Principals located in Italy, Portugal and 1 more location. Indaco Venture Partners' team sits on the board of 1 company.Here is a list of top team members in Indaco Venture Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Milan | - | ||
Partner | Lisbon | - | - | |
Partner | Milan | - | ||
Partner | Milan | - | - | |
Partner | Rome | - | ||
Partner | Milan | - | ||
Partner | Milan | - | - | |
Partner | Milan | - | - | |
Partner | Milan | - | - | |
Partner | Milan | - | - |
Co-investors of Indaco Venture Partners
Over the past 18 years, 156 investors have co-invested in Indaco Venture Partners's portfolio companies. This includes funds and angels.
- Invested before Indaco Venture Partners: Europa, EIC Fund and 56 others have invested in rounds before Indaco Venture Partners. There are 7 companies where Europa has invested before Indaco Venture Partners and 6 companies where EIC Fund has invested before Indaco Venture Partners.
- Top Co-investors of Indaco Venture Partners: 66 investors entered a company along with Indaco Venture Partners. These include investors like CDP Venture Capital (7 companies).
- Invested after Indaco Venture Partners: A total of 32 investors have invested in Indaco Venture Partners's portfolio after their investments. Top Investors include European Investment Bank (3 companies), ENEA Tech e Biomedical (3 companies) and Europa (3 companies).
Recent News related to Indaco Venture Partners
•
Wise Acquires Expatica to Enhance Support for International ResidentsFintech Finance•Jun 18, 2026•Wise, Expatica, European Investment Bank, EUREKA and 1 other
•
WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and BiomedicalBusiness Wire•Jun 17, 2026•WISE, ENEA Tech e Biomedical, Enea, Wise and 6 others
•
Newcleo Raises $85 Million to Advance Fourth-Generation Nuclear ReactorsBorn2Invest•Feb 04, 2026•Newcleo, NextChem, Walter Tosto, Cementir and 3 others
•
Newcleo Raised EUR 75 Million From Italian Investorshttps://www.worldenergynews.gr/•Feb 04, 2026•Cementir, Danieli, Newcleo, Orionvalves and 5 others
•
D-Orbit raises $128 million in first tranche of Series D fundingSpaceNews•Jan 22, 2026•D-Orbit, Azimut, Thriving Through Venture, Indaco Venture Partners
•
CamGraPhIC Raises €25M in Series A FundingFinSMEs•Mar 24, 2025•Indaco Venture Partners, Frontier IP, Robert Bosch Venture Capital, Join Capital and 4 others
•
Valo Therapeutics Receives EUR 19M in FundingFinSMEs•Mar 10, 2025•Valo Therapeutics, Indaco Venture Partners, CDP Venture Capital, ENEA Tech e Biomedical and 3 others
•
Valo Therapeutics announces EUR 19m of investment funding and expanded clinical trialsBenzinga•Mar 10, 2025•Valo Therapeutics, Indaco Venture Partners, CDP Venture Capital, Fondazione Edmund Mach
•
Newronika Closes €13.6M Series B FinancingFinSMEs•Feb 13, 2025•Newronika, TNT Capital, Wille Finance, Innogest Capital and 3 others
•
Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS PlatformPR Newswire•Feb 13, 2025•Newronika, ENEA Tech e Biomedical, Indaco Venture Partners, Innogest Capital and 2 others
